Company intelligence / Profile preview

Imaging Diagnostic Systems

Orlando, Florida, United Statesimds.com ↗

Ownership: Private
Development stage: Commercial

Overview

The CTLM® system provides non-invasive 3D laser-based imaging of breast tissue without compression or ionizing radiation. It aims to improve detection of abnormal vascular patterns linked to malignancy, especially useful for women with dense breasts. Clinical studies have compared its performance to conventional mammography. No large-scale pivotal trial results or regulatory approvals are cited.

Therapeutic areas: OncologyWomen's Health
Modalities: DeviceOptical imaging system
Industry: Medical Imaging

Partnerships

Jainsons Pty Ltd. Co. appointed as distributor for certain regions

Beyond the preview

Go deeper on Imaging Diagnostic Systems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Imaging Diagnostic Systems.

Explore the full profile